Biotech
> BioAmber hired Mario Saucier as its chief financial officer. Release
> Crescendo Biologics appointed Kevin Johnson as its new chairman. Release
> Angela Wilson joined NantKwest ($NK) as chief financial officer. Release
> Ambrx hired Dr. Yong-Jiang Hei as its chief medical officer. Release
> Grace Lytle joined Avellino Labs as its senior medical director. Release
> Atlas Genetics appointed Keith Stauffer as its vice president of sales and marketing. Release
> Analyst Geoffrey Porges joined Leerink Partners as its managing director, senior biotechnology analyst and director of therapeutics research. Release
> Synergy Pharmaceuticals ($SGYP) brought on Gary Sender as its chief financial officer. Release
> Immune Pharma ($IMNP) appointed Dr. Miri Ben-Ami as president of Immune Pharmaceuticals Israel and executive vice president of oncology, and Dr. Monica Luchi as executive vice president of global drug development and chief medical officer. Release
> Purdue Pharma named Dr. Alan Dunton as senior vice president of research and development. Release
> West Pharmaceutical Services ($WST) named George Miller senior vice president, general counsel and corporate secretary. Release
> NovaBay Pharma's ($NBY) CEO, Ron Najafi, stepped down. Chairman Mark Sieczkarek will serve as interim president and CEO. Release
> Afferent Pharma appointed Prabha Ibrahim as chief technology officer and Michelle Carpenter as vice president, regulatory affairs and project management. Release
> Boston Pharma appointed Dr. Santiago Arroyo as chief medical officer and Constantine Chinoporos as chief business officer. Release
> C4X Discovery announced the appointment of Dr. Clive Dix as executive chairman and the departure of CEO Piers Morgan. Release
> Diaceutics Group named Steve Vitale managing director of analytics, insights and strategy division. Release
> Idera Pharma ($IDRA) named Dr. Joanna Horobin as chief medical officer. Release
> BioTime ($BTX) appointed Russell Skibsted as chief financial officer. Release
> Inivata appointed James Clark as vice president of clinical laboratory operations. Release
> Oncimmune named Dr. James Jett as chief medical officer. Release
CRO
> Dr. Glynis Neagle joined Medpace as vice president of medical affairs. Release
Diagnostics
> Natera ($NTRA) appointed Jimmy Lin as chief scientific officer for oncology. Release
> PlaqueTec named Dr. Nick West as chief medical officer. Release
Med tech
> Shameze Rampertab stepped down from his position as CFO of Profound Medical. Release
> Cardiovascular Systems CEO David Martin is taking a medical leave of absence. Chairman Scott Ward will serve as the interim CEO. Release
> Egalet ($EGLT) brought on Paul Varki as its senior vice president and general counsel. Release
> Hamilton Thorne hired Keith Edwards as senior vice president and general manager. Release
|